Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
Conditions:   C3 Glomerulopathy;   Membranoproliferative Glomerulonephritis;   Complement Abnormality;   Dense Deposit Disease;   C3 Glomerulonephritis Interventions:   Drug: Aliskiren;   Drug: Enalapril Sponsor:   Region Skane Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2019 Category: Research Source Type: clinical trials

The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function
Condition:   High Blood Pressure Interventions:   Drug: Aliskiren;   Drug: Placebo;   Drug: Hydrochlorothiazide Sponsor:   Vanderbilt University Completed - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2017 Category: Research Source Type: clinical trials